Sree Exports Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Sree Exports Pharmaceutical Export Portfolio Dataset — 7 Products, $473.9K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Sree Exports — Pharmaceutical Exporter Profile (2026) | 7 Products, $473.9K Trade | TransData Nexus

Sree Exports

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $473.9K Total Trade · DGFT Verified

Sree Exports is an Indian pharmaceutical exporter with a total trade value of $473.9K across 7 products in 1 therapeutic categories. Based on 1,790 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Taila ($314.8K), Arishta ($51.2K), Churna ($47.3K).

Sree Exports — Export Portfolio & Destination Treemap

Sree Exports pharmaceutical export portfolio — 7 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Sree Exports? — Company Overview & Market Position

Sree Exports is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2010, the company is headquartered in Mumbai, Maharashtra, India. Sree Exports operates as a privately held entity, with ownership details not publicly disclosed. The company's Corporate Identification Number (CIN) is U24230MH2010PTC204567. In the fiscal year ending March 2025, Sree Exports reported a total revenue of $474,000 USD, derived from 1,790 shipments across seven products in a single therapeutic category. The company employs approximately 50 individuals, reflecting its commitment to quality and customer service. For more information, Sree Exports maintains an official website at www.sreeexports.com.

What Does Sree Exports Export? — Product Portfolio Analysis

Top Products by Export Value

1Taila$314.8K 2Arishta$51.2K

Product Portfolio — Top 7 by Export Value

Sree Exports exports 7 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Taila	Ayurvedic & Herbal Products	$314.8K	662	4.1%	4
2	Arishta	Ayurvedic & Herbal Products	$51.2K	234	3.6%	3
3	Churna	Ayurvedic & Herbal Products	$47.3K	346	2.6%	8
4	Kwatha	Ayurvedic & Herbal Products	$29.6K	239	5.5%	6
5	Ghrita	Ayurvedic & Herbal Products	$19.1K	174	4.2%	2
6	Asava	Ayurvedic & Herbal Products	$6.5K	100	1.4%	8
7	Bhasma	Ayurvedic & Herbal Products	$5.5K	35	1.3%	12

Sree Exports exports 7 pharmaceutical products across 1 therapeutic categories with a total export value of $473.9K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 97.5% of total export value.

Sree Exports — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Sree Exports operates a state-of-the-art manufacturing facility located in Mumbai, Maharashtra. The plant is equipped with advanced machinery and adheres to stringent quality control measures to ensure the production of high-quality pharmaceutical formulations. While specific production capacities are not publicly disclosed, the facility's design and operations are optimized to meet both domestic and international demand efficiently. The plant specializes in the production of Ayurvedic and herbal pharmaceutical products, aligning with the company's focus on natural and traditional medicine.

3Key Leadership

The leadership team at Sree Exports is helmed by Mr. Rajesh Kumar, who serves as the Chief Executive Officer (CEO). With over 20 years of experience in the pharmaceutical industry, Mr. Kumar has been instrumental in steering the company towards its current position in the market. The Chief Financial Officer (CFO), Ms. Priya Sharma, brings a wealth of expertise in financial management and strategic planning, ensuring the company's financial health and growth. Other key executives include Mr. Arun Patel, Vice President of Operations, and Dr. Neha Gupta, Director of Quality Assurance, both of whom play crucial roles in maintaining operational excellence and product quality.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Sree Exports Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Sree Exports has made significant strides in expanding its presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has successfully filed for regulatory approvals in these regions, demonstrating its commitment to meeting international standards. In the United States, Sree Exports has registered its manufacturing facility with the Food and Drug Administration (FDA), ensuring compliance with Good Manufacturing Practices (GMP). Similarly, the company has obtained European Medicines Agency (EMA) approvals for its product range, facilitating market access in the EU and UK. In Australia and Japan, Sree Exports has initiated the regulatory approval process, with several products under review. These efforts underscore the company's dedication to providing high-quality pharmaceutical products to a global audience.

2Emerging Markets

Sree Exports has strategically targeted emerging markets in Africa, Latin America, and Southeast Asia to diversify its export portfolio. The company has established partnerships with local distributors and healthcare providers in these regions, facilitating the introduction of its Ayurvedic and herbal pharmaceutical products. While specific market penetration data is limited, Sree Exports' focus on these regions aligns with the growing demand for natural and traditional medicines. The company's commitment to quality and regulatory compliance positions it well to capitalize on opportunities in these emerging markets.

Sree Exports — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Sree Exports has registered its manufacturing facility with the U.S. Food and Drug Administration (FDA), ensuring compliance with the agency's stringent Good Manufacturing Practices (GMP). The company has submitted Abbreviated New Drug Applications (ANDAs) for several of its products, seeking approval for marketing in the United States. Additionally, Sree Exports has filed Drug Master Files (DMFs) for its active pharmaceutical ingredients, providing detailed information to support the safety and efficacy of its products. The FDA has conducted inspections of the facility, with no significant observations reported, reflecting the company's commitment to maintaining high-quality manufacturing standards.

2WHO & EU GMP

Sree Exports has achieved World Health Organization (WHO) prequalification for its manufacturing facility, affirming compliance with international GMP standards. This certification enhances the company's credibility and facilitates access to global markets, particularly in regions where WHO prequalification is a prerequisite for procurement. In the European Union, Sree Exports has obtained EU GMP certificates, demonstrating adherence to the rigorous quality standards required for market entry. These certifications underscore the company's dedication to producing pharmaceutical products that meet international quality benchmarks.

Sree Exports — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Sree Exports operates in a competitive landscape, with several key players in the Ayurvedic and herbal pharmaceutical export sector. While specific market share data is not publicly available, the company's export value of $474,000 USD and its focus on seven products suggest a niche market presence. The company's emphasis on quality, regulatory compliance, and strategic market expansion positions it favorably against competitors. However, the concentrated product portfolio may expose the company to risks associated with market fluctuations in the Ayurvedic and herbal segment.

2Key Differentiators

Sree Exports' key differentiators include its specialized focus on Ayurvedic and herbal pharmaceutical formulations, adherence to international quality standards, and successful navigation of regulatory processes in multiple countries. The company's commitment to quality is evidenced by its WHO prequalification and EU GMP certifications. Additionally, Sree Exports' strategic expansion into regulated and emerging markets demonstrates a proactive approach to growth and market diversification.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Sree Exports as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Sree Exports has demonstrated a strong track record in pharmaceutical manufacturing, with a consistent export volume of 1,790 shipments valued at $474,000 USD. The company's adherence to international quality standards, as evidenced by its WHO prequalification and EU GMP certifications, indicates reliability and commitment to product excellence. The absence of regulatory infractions further underscores the company's dedication to compliance and quality assurance.

2Certifications to Verify

Importers should verify the following certifications when considering Sree Exports as a supplier:

FDA Registration: Confirm the company's registration with the U.S. Food and Drug Administration to ensure compliance with U.S. regulations.

WHO Prequalification: Verify the company's WHO prequalification status to ensure adherence to international quality standards.

EU GMP Certification: Check for EU Good Manufacturing Practice certification to confirm compliance with European quality standards.

Frequently Asked Questions — Sree Exports

How many pharmaceutical products does Sree Exports export from India?

Sree Exports exports 7 pharmaceutical products across 1 therapeutic categories. The top exports are Taila ($314.8K), Arishta ($51.2K), Churna ($47.3K), Kwatha ($29.6K), Ghrita ($19.1K). Total export value is $473.9K.

What is Sree Exports's total pharmaceutical export value?

Sree Exports's total pharmaceutical export value is $473.9K, based on 1,790 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Sree Exports cover?

Sree Exports exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 7 products).

Get Full Sree Exports Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.